# Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate

> **NCT00102882** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 547 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone propionate/salmeterol
- **DRUG:** salmeterol xinafoate

## Key facts

- **NCT ID:** NCT00102882
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 547 (ACTUAL)
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102882, "Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00102882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*